| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |